최종기 (울산대학교 의과대학, 서울아산병원)님 | 한빛사연구자 > 한빛사

울산대학교 의과대학, 서울아산병원

CV File

응용의학

최종업데이트 2024.05.17.

- 최종기(울산대학교 의과대학, 서울아산병원, Massachusetts General Hospital)
Association between statin use and hepatic decompensation in patients with primary biliary cholangitis: A target trial emulation study
- Hepatology, Feb 02 2026, | https://doi.org/10.1097/HEP.0000000000001701
- 2026-02
- 의약학
- 한빛사논문
- 최종기(울산대학교 의과대학, 서울아산병원, Massachusetts General Hospital)
Comparative Risk of Fibrosis Progression with SGLT2 vs. DPP-4 Inhibitors in MASLD and T2DM with Low-to-Intermediate Fibrosis
- Clin. Mol. Hepatol., Nov 11 2025, | https://doi.org/10.3350/cmh.2025.0825
- 2025-11
- 의약학
- 한빛사논문
- 최종기(울산대학교 의과대학, 서울아산병원)
Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver Disease
- JAMA Intern. Med., Mar 17 2025, | https://doi.org/10.1001/jamainternmed.2025.0115
- 2025-03
- 의약학
- 한빛사논문
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial
- Lancet Gastroenterol. Hepatol., Jan 31 2025, S2468-1253(24)00431-X | https://doi.org/10.1016/S2468-1253(24)00431-X
- 2025-01
- 의약학
- 한빛사논문
Updated Reference Intervals for Alanine Aminotransferase in a Metabolically and Histologically Normal Population
- Clin. Gastroenterol. Hepatol., May 13 2024, S1542-3565(24)00439-7 | https://doi.org/10.1016/j.cgh.2024.04.031
- 2024-05
- 의약학
- 한빛사논문
Increased Risk of Osteoporotic Fracture in Patients with Autoimmune Hepatitis
- Am. J. Gastroenterol., 2023 Jun 13 | doi: 10.14309/ajg.0000000000002354
- 2023-06
- 의약학
- 한빛사논문
Liver Cirrhosis Increases the Risk of Herpes Zoster: A Nationwide Population-based Cohort Study
- Am. J. Gastroenterol., February 03, 2023 | doi: 10.14309/ajg.0000000000002209
- 2023-02
- 의약학
- 한빛사논문
Validation of The Model for End-Stage Liver Disease 3.0 in Korean Patients on the Liver Transplant Waiting List
- Clin. Gastroenterol. Hepatol., Published:January 31, 2023 | https://doi.org/10.1016/j.cgh.2023.01.020
- 2023-01
- 의약학
- 한빛사논문
Tenofovir Alafenamide for Multiple Drug-Resistant Chronic Hepatitis B: A 3-Year Clinical Trial
- Clin. Gastroenterol. Hepatol., 2023 Jan 11;S1542-3565(22)01183-1 | https://doi.org/10.1016/j.cgh.2022.12.016
- 2023-01
- 의약학
- 한빛사논문
Low level of hepatitis B viremia compared with undetectable viremia increases the risk of hepatocellular carcinoma in patients with untreated compensated cirrhosis
- Am. J. Gastroenterol., 2023 Jan 9 | doi: 10.14309/ajg.0000000000002181
- 2023-01
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기